3. 10. 2011 » 15. 10. 2011 Translational Research in CNS Diseases kurz e-mail: info@nsas.ittel.: +39 0577 897216, +39 0577 1730037 www: http://www.nsas.it/translational-research-in-cns-diseases
10. March 2026 From essential medicine to illicit commodity: new EU report reveals how ketamine diversion is fuelling the illicit market in Europe Ketamine produced legitimately outside the EU to make medicines is increasingly finding its way onto Europe’s illicit drug...